Concentrated Australian Share Fund
The Investors Mutual Concentrated Australian Share Fund provides exposure to an actively managed, concentrated portfolio of quality shares listed on the ASX. The Fund will aim to provide attractive investment opportunities for investors seeking medium to long term capital growth with income. The Fund applies IML’s conservative value based investment philosophy with a long term focus and aims to deliver consistent returns to clients.
Investors Mutual Concentrated Australian Share Fund
Hugh Giddy provides an introduction to the Investors Mutual Concentrated Australian Share Fund, the companies it invests in, the outcomes of the fund & how it differs from a stereotypical concentrated fund.
S&P/ASX 300 Accumulation Index
1 Sept 2010
145 759 879
10.25% (10% inclusive of the net effect of GST) of investment returns made in excess of 2% above the Benchmark.
0.993% p.a. of the net assets of the fund (includes GST)
The Fund aims to provide a rate of return (after fees and expenses and before taxes) which exceeds the return of the S&P/ASX 300 Accumulation Index on a rolling five year basis.
The Fund will invest in a concentrated portfolio of quality ASX listed Australian and New Zealand shares, where these shares are identified by our investment team as being undervalued.
Past performance is not indicative of future performance as a result past distributions are not indicative of future distributions.For more information please refer to our Distributions page
Ratings and awards
For the most recent research house ratings report please contact your state manager.
The Lonsec Rating (assigned 9 November 2016) presented in this document is published by Lonsec Research Pty Ltd ABN 11 151 658 561 AFSL 421 445. The Rating is limited to “General Advice” (as defined in the Corporations Act 2001 (Cth)) and based solely on consideration of the investment merits of the financial product(s). Past performance information is for illustrative purposes only and is not indicative of future performance. It is not a recommendation to purchase, sell or hold [Fund Manager name] product(s), and you should seek independent financial advice before investing in this product(s). The Rating is subject to change without notice and Lonsec assumes no obligation to update the relevant document(s) following publication. Lonsec receives a fee from the Fund Manager for researching the product(s) using comprehensive and objective criteria. For further information regarding Lonsec’s Ratings methodology, please refer to our website at: http://www.beyond.lonsec.com.au/intelligence/lonsec-ratings
The Zenith Investment Partners (“Zenith”) Australian Financial Services License No. 226872 rating (assigned 30 June 2016) referred to in this document is limited to “General Advice” (as defined by the Corporations Act 2001) for Wholesale clients only. This advice has been prepared without taking into account the objectives, financial situation or needs of any individual. It is not a specific recommendation to purchase, sell or hold the relevant product(s). Investors should seek independent financial advice before making an investment decision and should consider the appropriateness of this advice in light of their own objectives, financial situation and needs. Investors should obtain a copy of, and consider the PDS or offer document before making any decision and refer to the full Zenith Product Assessment available on the Zenith website. Zenith usually charges the product issuer, fund manager or a related party to conduct Product Assessments. Full details regarding Zenith’s methodology, ratings definitions and regulatory compliance are available on our Product Assessment’s and at http://www.zenithpartners.com.au/RegulatoryGuidelines